1. Home
  2. BGLC vs MNDR Comparison

BGLC vs MNDR Comparison

Compare BGLC & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$1.63

Market Cap

4.4M

Sector

Health Care

ML Signal

N/A

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$3.01

Market Cap

4.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
MNDR
Founded
2017
2016
Country
Malaysia
Singapore
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.0M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
BGLC
MNDR
Price
$1.63
$3.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.2K
187.9K
Earning Date
04-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$7,424,911.00
N/A
Revenue This Year
N/A
$608,852.40
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.40
52 Week High
$8.98
$5.42

Technical Indicators

Market Signals
Indicator
BGLC
MNDR
Relative Strength Index (RSI) 33.82 64.48
Support Level $1.55 $0.76
Resistance Level $2.15 $3.90
Average True Range (ATR) 0.11 0.29
MACD -0.02 -0.06
Stochastic Oscillator 14.02 9.52

Price Performance

Historical Comparison
BGLC
MNDR

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

Share on Social Networks: